Krabbe disease successfully treated via monotherapy of intrathecal gene therapy is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: NIH/NINDS R01-NS-096087
National Institutes of Health
Grant: NIH P40-OD-010939
National Institutes of Health
Grant: NIH/NINDS F32NS093898
National Institutes of Health
Grant: NIH/NICHD 1K99HD096115
National Institutes of Health
Grant: R01 NS065808
NINDS NIH HHS
Grant: F32 NS093898
NINDS NIH HHS
Grant: R01 NS096087
NICHD NIH HHS
Grant: K99 HD096115
NIH HHS
Grant: P40 OD010939
NINDS NIH HHS
Grant: R01 NS100779
National Institutes of Health
Grant: 1K99HD096115-01
Temporospatial psychosine accumulation and targeted adeno-associated virus (AAV) gene therapy in canine Krabbe disease
National Institutes of Health
Grant: 5P40OD010939-33
Referral Center-Animal models of human genetic disease
National Institutes of Health
Grant: 5R01NS096087-05
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease
National Institutes of Health
Grant: 5R01NS065808-03
Combined neuroprotection and metabolic correction to treat leukodystrophies
National Institutes of Health
Grant: 1F32NS093898-01A1
Lentiviral-mediated Hematopoietic Stem Cell Gene Therapy for Canine Globoid Cell Leukodystrophy
FWCI
5.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 1 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 2 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 2 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 3 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 3 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 4 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 4 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 5 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling
Additional file 5 of Identifying altered developmental pathways in human globoid cell leukodystrophy iPSCs-derived NSCs using transcriptome profiling